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Original Article

General practitioners’ knowledge and approach to
chronic kidney disease in Karachi, Pakistan
S.Yaqub, W. Kashif, M.Q. Raza1, H. Aaqil1, A. Shahab1, M.A. Chaudhary1, S. A. Hussain
Department of Medicine, Section of Nephrology, Aga Khan University Hospital, 1Aga Khan University Medical College, Stadium Road, Karachi,
Pakistan

ABSTRACT
Due to lack of adequate number of formally trained nephrologists, many patients with chronic kidney disease (CKD) are seen by
general practitioners (GPs). This study was designed to assess the knowledge of the GPs regarding identification of CKD and
its risk factors, and evaluation and management of risk factors as well as complications of CKD. We conducted a cross‑sectional
survey of 232 randomly selected GPs from Karachi during 2011. Data were collected on a structured questionnaire based on the
kidney disease outcomes and quality initiative recommendations on screening, diagnosis, and management of CKD. A total of
235 GPs were approached, and 232 consented to participate. Mean age was 38.5 ± 11.26 years; 56.5% were men. Most of the
GPs knew the traditional risk factors for CKD, i.e., diabetes (88.4%) and hypertension (80%), but were less aware of other risk
factors. Only 38% GPs were aware of estimated glomerular filtration rate in evaluation of patients with CKD. Only 61.6% GPs
recognized CKD as a risk factor for cardiovascular disease. About 40% and 29% GPs knew the correct goal systolic and diastolic
blood pressure, respectively. In all, 41% GPs did not know when to refer the patient to a nephrologist. Our survey identified
specific gaps in knowledge and approach of GPs regarding diagnosis and management of CKD. Educational efforts are needed
to increase awareness of clinical practice guidelines and recommendations for patients with CKD among GPs, which may improve
management and clinical outcomes of this population.
Key words: Chronic kidney disease, general practitioners, glomerular filtration rate, practice guidelines

Introduction
Chronic kidney disease (CKD) is a major public health
problem worldwide. [1,2] The social and economic
implications of CKD are substantial not only due to
morbidity and mortality associated with the progression
to kidney failure, but also because of its association with
accelerated cardiovascular disease (CVD).[3] The ultimate
outcome of CKD in many patients is the need for renal
replacement therapy, which necessitates ever‑growing
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dialysis and transplantation programs, thereby imposing
a significant economic burden on the healthcare system.
Prevention, early detection, and timely intervention are
the only cost‑effective strategies. CKD can be detected
using simple laboratory tests, and certain treatments
can prevent or delay complications of decreased kidney
function, slow the progression of kidney disease, and
reduce its associated CVD risk.[4,5] This is especially
pertinent to developing countries, where support for
renal replacement therapy is lacking for the vast majority
of patients with advanced kidney disease due to severe
financial constraints.[6]
At present, there are only about 80 formally trained
nephrologists in Pakistan for a population of about 160
million (the USA has more than 5000 nephrologists for
a population of about 300 million).[7] Until the public
health services in Pakistan are developed further, general
practitioners (GPs) will continue to be the frontline
caregivers in Pakistan. Using the available evidence‑based
guidelines, the GPs should be able to detect, monitor,
and treat CKD early in the course of the disease, thereby
reducing mortality and improving quality of life for their
patients. Currently, there has been no study in the region
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describing how the GPs are doing in incorporating these
guidelines in their clinical practice. The current study was
designed to assess the knowledge of GPs in detection and
treatment of CKD and to see whether it is in accordance
with the international guidelines for prevention, early
detection, and management of CKD.

Materials and Methods
We conducted a cross‑sectional survey of the GPs
practicing in Karachi to assess their knowledge and
approach toward the diagnosis and management of CKD.
Survey instrument
We reviewed the official Kidney Disease Outcomes and
Quality Initiatives (KDOQI) guidelines on screening,
diagnosis, and management of CKD developed by the
National Kidney Foundation (NKF).[8] We identified
themes relevant to GPs providing pre‑dialysis CKD
care. Data were collected on a structured questionnaire
developed containing questions on the following basic
themes:
• Type of practice – location of clinic, duration of
practice, affiliation with teaching hospitals, additional
postgraduate qualifications beyond basic medical
qualification (MBBS), and average number of patients
seen per day.
• Detection of CKD and its risk factors such as diabetes,
hypertension, old age, and family history of kidney
disease.
• Screening for CKD – when to screen patients with
type 1 and type 2 diabetes.
• Complications of CKD – CVD, hypertension, anemia,
hyperparathyroidism, etc.
• Management goals in CKD – target systolic and diastolic
blood pressure (BP), target glycated hemoglobin
(HbA1c), target serum low‑density lipoprotein (LDL)
cholesterol, first‑line antihypertensive therapy to
control both BP and proteinuria, and antihypertensive
agents routinely used in CKD.
• Referral to a nephrologist – at what level of glomerular
filtration rate (GFR) a CKD patient should be referred
to nephrologist.
• Source of information about CKD – medical journals
and/or continued medical education (CME) activities.
The questionnaire was validated by four consultant
nephrologists. The questionnaire was pretested in a pilot
study on 10 GPs and was finalized after necessary changes
based on the feedback.
Sample size
Based on the assumptions that about 30% of GPs did not
follow the standard guidelines for prevention, detection,
Indian Journal of Nephrology

and management of CKD, a total of 225 subjects were
needed for the study. We anticipated a nonresponse rate
of about 4%, so our required sample size was 234 GPs.
Sampling
We performed a cross‑sectional survey of GPs practicing
in Karachi during May to June 2011. Karachi is the largest
and most cosmopolitan city in Pakistan, with a population
of approximately 18 million. The city is divided into 18
administrative units known as towns. We obtained a
comprehensive list of 5000 GPs practicing in Karachi
from a medical database published in a book form called
“The Mediguide.” A computer‑generated random sample
of 234 GPs was selected from this list. The GPs surveyed
had their practices in 12 of the 18 towns in the city and
represented all socioeconomic classes. Each GP was
visited by a trained research officer who administered
the study questionnaire after obtaining written informed
consent from the GP. Each GP was given 15‑20 min to
fill the questionnaire at the spot. In case the selected
GP was not present, their replacement was chosen from
the same area. The identity of the GPs was kept strictly
confidential.
Statistical analysis
All statistical analyses were conducted using the Statistical
package for social science SPSS (Release 15.0, standard
version, copyright© SPSS; 1989‑02). A descriptive analysis
was carried out for demographic characteristics and
results, and presented as mean ± standard deviation.
Frequencies and percentage were calculated for gender,
teaching affiliation, and postgraduate qualifications.

Results
A total of 235 GPs were approached, and 232 consented
to participate in the survey.
Demographics
Mean age of the GPs (±SD) was 38.5 years (±11.26). Of
the study GPs, 132 (57%) were men. The average number
of years since practicing as a GP was 12 (±10) years. The
average number of patients seen by the GP per day was
57 (±67). A total of 61 (26.3%) GPs were affiliated with
teaching hospitals and 71 GPs (30.6%) claimed to hold
postgraduate qualifications beyond MBBS.
Identification of risk factors and screening
A total of 205 (88.4%) GPs recognized diabetes to be a
risk factor for CKD, and hypertension was identified as a
risk factor by 185 GPs (79.7%). However, they were less
likely to identify other risk factors for CKD, such as age
older than 60 years (33.6%) and family history of kidney
disease (42.2%).
May 2013 / Vol 23 / Issue 3
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When questioned about as to when to screen patients with
type 1 diabetes for kidney disease, only 29 GPs (12.5%)
answered correctly. However, most of them (77.2%) knew
as to when to screen type 2 diabetics.

was chosen by 23.3% GPs, 15‑29 ml/min by 19.8%, and
less than 15 ml/min by 15.1% GPs, whereas 40.9% GPs
responded that they did not know when to refer the
patient to a nephrologist.

Detection of chronic kidney disease and its
complications
The participants were asked to identify the best method
to estimate kidney function. Serum creatinine was the
most common choice (78.1%), followed by 24 h urine
collection for creatinine clearance (63.8%). Estimated
glomerular filtration rate (eGFR) using a mathematical
formula was chosen by only 58 GPs (37.9%).

Sources of information
Only half the GPs reported reading medical journals in
order to keep themselves updated, whereas approximately
33% GPs claimed to participate in CME activities held at
various tertiary care hospitals.

Management
The correct levels of target systolic and diastolic BP in CKD
patients were aimed for by only 93 (40.1%) and 67 GPs
(28.9%), respectively [Figure 2]. Only 107 (46.1%) GPs
chose Angiotensin converting enzyme inhibitors (ACE) or
angiotensin receptor blockers (ARBs) when questioned about
the first‑line therapy to control both BP and proteinuria in
order to slow down the progression of CKD.
The correct target HbA1c in patients with diabetes and
CKD was aimed for by 124 GPs (53.4%). However, only
50 GPs (21.6%) were aware of the correct level of target
LDL cholesterol in CKD patients.
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Referral to a nephrologist
There was uncertainty among the GPs about when to refer
to a nephrologist. An estimated GFR of 30‑60 ml/min

Figure 1: Proportion of GPs who identified the listed conditions as
complications of CKD
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The results of our GP survey highlight the areas that need
to be worked upon in order to improve the quality of care
and outcomes for patients with CKD. In Pakistan, patients
suffering from CKD are mainly under care of internists
and GPs until they reach advanced kidney failure when
they are referred to a nephrologist. Delayed referral of
CKD patients to a nephrologist has been identified as
an important predictor of poor outcomes.[9] In order to
initiate timely referral of CKD patients, primary care
providers and family physicians need to be aware of risk
factors for CKD, screening methods, as well as comorbid
conditions and complications associated with CKD. In
addition, they should be aware of the clinical practice
guidelines describing optimal care of patients with CKD.
The NKF’s KDOQI work‑group released evidence‑based
guidelines, in 2002, to increase awareness of these
secondary prevention strategies in the care of CKD.[8]
These are the only known evidence‑based guidelines for
pre‑dialysis CKD care. Incorporation of these guidelines
into clinical practice facilitates early detection of
CKD by primary care providers and identification and
management of its complications, and promotes timely
referral of patients to nephrology services.
Traditionally, physicians have been relying on measurement
of serum creatinine alone for detection of kidney disease.
The KDOQI guidelines recommend that serum creatinine
alone is not an accurate index of the level of GFR and
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When asked what conditions were complications of CKD,
most GPs (83.2%) recognized anemia as a complication.
Bone disease and secondary hyperparathyroidism were
identified by 53.4% only and malnutrition by 47.8% GPs.
Other complications such as volume overload, hyperkalemia,
metabolic acidosis, and worsening hypertension were
considered by very few of them [Figure 1]. Only 61.6% GPs
recognized CKD as a risk factor for CVD.

Discussion
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Figure 2: Target systolic and diastolic BP (mm of Hg) chosen by the GPs
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that the level of GFR should be estimated from prediction
equations that take into account the serum creatinine
concentration and some or all of the following variables:
Age, gender, race, and body size.[8] Our results indicate
that only 38% physicians opt for eGFR for detection of
CKD and most of the GPs preferred serum creatinine
and/or 24 h urine collection for creatinine clearance. A
study involving 10 primary care providers from New York
showed similar findings as far as physicians’ preferences
for kidney disease diagnostic tests were concerned. Only
one of the physicians interviewed reported using eGFR,[10]
whereas the rest of them relied upon blood urea, serum
creatinine, or urinalysis for diagnosis of CKD. Results
from a cross‑sectional study, based upon different groups
of physicians at a tertiary care hospital in Pakistan,
showed that majority of the study subjects (78%) were
aware of eGFR being a better way of assessing severity of
kidney disease than elevated serum creatinine alone.[11]
Using serum creatinine alone may result in significant
under‑recognition of CKD as the level may still be within
normal range even when kidney function is significantly
impaired. Measurement of creatinine clearance requires
collection of a timed urine sample, which is inconvenient
and frequently inaccurate. In order to identify patients
with early CKD, estimation of GFR using formulae such
as the Cockcroft–Gault and modification of diet in renal
disease should be done.

should be screened annually for diabetic kidney
disease.[13] Initial screening should commence 5 years
after the diagnosis of type 1 diabetes and at the time of
diagnosis of type 2 diabetes. It is disappointing that almost
88% of the GPs surveyed do not know as to when to start
screening type 1 diabetics for the presence of kidney
disease. However, most of the physicians were aware of
screening patients with type 2 diabetes, which is the more
prevalent form of the disease. As far as management of
diabetic patients with CKD was concerned, only half the
GPs identified the correct target HbA1c. It is of particular
concern because diabetes is the leading cause of kidney
failure worldwide, and the prevalence is high in the South
Asian populations and is expected to increase two‑fold
between 2000 and 2030.[14] Appropriate screening, early
detection, and timely intervention including management
of diabetes and hypertension are the only strategies
that can slow kidney disease progression and reduce
cardiovascular risk. In 2007, the KDOQI work‑group
released evidence‑based clinical practice guidelines and
clinical practice recommendations for screening and
management of patients with diabetes and CKD.[13] A vast
majority of patients with diabetes and kidney disease are
under care of GPs in our part of the world owing to huge
burden of the disease and lack of adequate number of
nephrologists. Hence it needs to be ensured that our GPs
are well versed in detection and management of diabetes
and diabetic kidney disease.

Epidemiologic studies show an increased risk for
CKD among individuals with certain clinical and
sociodemographic characteristics, including older age, race
(African–Americans), diabetes, hypertension, autoimmune
diseases, urinary tract infections, stone disease, neoplasia,
family history of CKD, etc.[8] It cannot be overemphasized
that prevention of adverse outcomes of CKD could be
facilitated by evaluating individuals with these risk factors
to enable earlier detection and intervention. In our survey,
diabetes and hypertension were identified as risk factors for
CKD by most of the physicians, whereas other risk factors
for CKD such as age older than 60 years and family history
of kidney disease did not receive the same recognition.
Data from a web‑based survey in the USA, which included
376 family medicine and internal medicine trainees,
show similar results.[12] Whereas almost all physicians
identified diabetes and hypertension as strong risk factors
for CKD, minority status, old age, or family history were
not universally recognized. The authors speculated that it
would be more challenging to emphasize the contribution
of risk factors such as race, ethnicity, and old age, because
of the varying prevalence of comorbid diseases such as
hypertension.

Physicians involved in the care of CKD patients should pay
attention to a wide range of disorders that may develop
as a consequence of the loss of renal function. These
include disorders of fluid and electrolyte balance, such
as volume overload, hyperkalemia, metabolic acidosis,
and hyperphosphatemia, as well as abnormalities related
to hormonal or systemic dysfunction, such as anorexia,
nausea, vomiting, fatigue, hypertension, anemia,
malnutrition, hyperlipidemia, and bone disease. Onset
and severity of these complications are related to the level
of GFR. Below a GFR of approximately 60 ml/min, there is
a higher prevalence of abnormalities of bone metabolism,
anemia, malnutrition, and hypoalbuminemia. Other
complications such as volume overload, hyperkalemia,
and metabolic acidosis tend to occur when GFR falls
below 15‑20 ml/min. Our results showed that most of
the GPs recognized anemia, whereas bone disease and
secondary hyperparathyroidism, as well as malnutrition,
were identified as complications by only half of them. It is
important to recognize these disorders as complications
of CKD in order to reduce disease‑related morbidity and
mortality.

The American Diabetes Association and the KDOQI
work‑group recommend that patients with diabetes

Data from a number of epidemiologic studies have
identified hypertension as a risk factor for progression
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of CKD, and that from clinical trials confirm that
antihypertensive treatment reduces the risk.[15] Apart
from accelerating the progression of kidney disease, high
BP leads to high risk of CVD including death. The Joint
National Committee in their 7th report (JNC 7) and KDOQI
guidelines recommend a target BP of < 130/80 mm
Hg in patients with CKD.[16] It is alarming that a vast
majority of GPs are not aware of the optimal systolic
and diastolic BP for patients with kidney disease. Our
findings are very similar to those from another study from
Pakistan evaluating GPs’ approach toward hypertension in
general population, indicating a similar degree of under
treatment.[17] It was found that 47.7% of GPs aimed for
a target BP > 140/90 in the general population, and
the majority of GPs aimed for targets greater than those
recommended by the JNC guidelines for patients with
diabetes, kidney disease, and CVD.[17]
The KDOQI guidelines recommend ACE inhibitors and
ARBs as the preferred agents for diabetic kidney disease
and non‑diabetic kidney diseases with proteinuria.[16] In
these diseases, they lower BP, reduce proteinuria, slow
the progression of kidney disease, and likely reduce CVD
risk by mechanisms in addition to lowering BP. There is
substantial amount of evidence suggesting efficacy of this
class of drugs in decreasing albuminuria, and delaying the
progression from microalbuminuria to macroalbuminuria
in patients with proteinuria and CKD.[18‑20] Almost half
the GPs chose ACE inhibitors or ARBs as the first line
of treatment to control BP and proteinuria followed by
calcium channel blockers (34.9%), beta blockers (31%),
and thiazide diuretics (29.7%). It is noteworthy that the
GPs’ survey from Pakistan mentioned earlier had revealed
that almost 45% of GPs used sedatives either alone or
in combination with other antihypertensive agents as
first‑line therapy for hypertension.[17] Keeping these
observations in view, our survey indicates an improvement
in prescribing practices of GPs as far as the management
of hypertension is concerned.
All patients with a progressive increase in serum creatinine
level need referral to a nephrologist, and preparation
for renal replacement therapy ideally requires frequent
contact with a nephrologist over at least a year. Compared
with early referral, late referral has been found to be
associated with a significantly increased risk of morbidity
as well as all‑cause mortality. The potential benefits
associated with early referral include informed selection
of dialysis modality, timely placement of appropriate
dialysis access, non‑emergent initiation of dialysis, lower
morbidity and improved rehabilitation, less frequent and
shorter hospital stays, lower cost, improved survival,
and likelihood of preemptive transplant. In addition,
timely referral provides opportunities for appropriate
188
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intervention that would eventually slow down the
progression of CKD as well as reduce CVD risk. The KDOQI
guidelines recommend that patients with CKD should be
referred to a nephrologist when the eGFR is less than 60
ml/min. In our survey, we found an uncertainty among
our GPs about the appropriate time of referral. A vast
majority of GPs were not aware as to when to refer a CKD
patient to a nephrologist. Only 23% chose to refer when
GFR was below 60 ml/min. Data from the USA and other
developed as well as developing countries suggest that
late referrals are quite common. One study has shown that
approximately 25‑50% of patients beginning chronic renal
replacement therapy in the USA require dialysis within 1
month of their first nephrology visit.[21] In another study
from Pakistan, almost half (48%) the study subjects
were found to be unaware as to when to refer these
patients to nephrologists based on eGFR, although a vast
majority (84%) of the physicians knew that late referral
would result in complications and higher morbidity and
mortality.[11] Timely referrals to nephrologists can only
be made when the primary care providers have a better
understanding of the eGFR, including the level of GFR
at which referral is recommended.
Our findings emphasize the need to increase the GPs’
awareness and knowledge of the evidence‑based CKD
care as outlined in KDOQI guidelines. There is a need for
continually updating the medical schools’ curricula as well
as having structured and more frequent CME activities
at teaching hospitals, especially targeting the GPs. In
addition, knowledge regarding CKD can be improved by
the use of posters and leaflets displayed in hospitals as
well as by using the print (newspapers and journals) and
the electronic media (radio and television). The KDOQI
guidelines are quite extensive (over 200 pages) and
hence are cumbersome to read. The responsibility lays
with the physicians at the teaching hospitals, especially
the nephrology community, to summarize the KDOQI
guidelines into a one‑page educational tool providing the
key evidence‑based practical points of the guidelines so
that the GPs as well as other physicians involved in care
of CKD patients could actually put them into practice. The
key points that will help the GPs and internists improve
their diagnosis and management of CKD are summarized
in Table 1.
We noticed in our survey that most GPs were not aware
of using eGFR to diagnose CKD. One simple solution
could be requesting the laboratories to automatically
report the eGFR (without an extra charge) whenever a
serum creatinine is ordered. This is the current practice
in most of the developed countries. However, physicians
should be aware that GFR is influenced by age, gender,
and race.
Indian Journal of Nephrology
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Table 1: Key points to improve care of patients with
chronic kidney disease
1. E
 stimated GFR is more accurate than serum creatinine alone in
the diagnosis of CKD
2. C
 KD is classified into five stages depending upon GFR
3. R
 isk factors for CKD include older age, family history of CKD,
diabetes, hypertension, autoimmune diseases, urinary tract
infections, urinary stones, urinary tract obstruction, and long term
treatment with potentially nephrotoxic drugs (e.g., Non steroidal
anti inflammatory agents (NSAIDs) and lithium)
4. A
 ll patients who have risk factors for CKD should be screened
with both a urine test for albumin and a blood test for creatinine to
estimate GFR
5. W
 hen the GFR falls below 60 ml/min, patients develop
complications of CKD, which are hyperkalemia, metabolic
acidosis, volume overload, hypertension, anemia, bone disease,
malnutrition, and ischemic heart disease
6. T
 arget blood pressure control in patients with CKD is<130/80
7. ACE inhibitors and/or angiotensin receptor blockers are the first‑line
antihypertensive agents and slow down the progression of CKD
8. T
 arget HbA1c in patients with diabetes and CKD is<7%
9. T
 arget LDL cholesterol in patients with CKD is<100 mg/dl
10. Early referral to a nephrologist improves outcomes and patients
should be referred when the GFR is less than 60 ml/min

Conclusion
Our survey highlights the deficiencies and gaps in the
knowledge and practices of GPs in Karachi regarding
diagnosis and management of CKD. Educational efforts
are needed to increase awareness of clinical practice
guidelines and recommendations for patients with CKD
among GPs, which may improve management and clinical
outcomes of this population.
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Supplemental information: To be made available online

Available online: General Practitioners’ Knowledge and Practice Patterns in Chronic Kidney Disease
Questionnaire
ID No: ____________________________________________________________________
Age (years): _______________________________________________________________
Gender:  Male		

 Female

Location/Address: __________________________________________________________
Contact No.: _______________________________________________________________
Current placement other than clinic: __________________________________________
If yes:
Location: __________________________________________________________________
Position/Title: ______________________________________________________________
1. How many patients visit your clinic per day?
_______________________________________________________________________
2. Are you affiliated with any teaching hospital?
1.  Yes		

2.

 No

3. Do you hold any postgraduate degree/diploma beyond MBBS?
1.  Yes		

2.

 No

If yes, please specify: ____________________________________________________
4. For how many years have you been practicing?
_______________________________________________________________________
5.	Which population, do you think, is at high risk of developing chronic kidney disease (CKD)? (Tick all that apply)
1.

 Diabetic					2.

 Have family history of CKD

3.

 Hypertensive				4.

 Elderly (>60 years of age)

5. Others: ______________________________________________________________
6. When should patients with type 1 diabetes be screened for kidney disease?
1.

 At the time of diagnosis and annually thereafter

2.

 Five years after diagnosis and annually thereafter
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3.

 Yearly only

4.

 Never

5.

 Others _____________________________________________________

7. When should patients with type 2 diabetes be screened for kidney disease?
1.

 At the time of diagnosis and annually thereafter

2.

 Five years after diagnosis and annually thereafter

3.

 Yearly only

4.

 Never

5.

 Others _____________________________________________________

8. What is the best method to estimate kidney function? (Tick all that apply)
1.

 Serum creatinine/blood urea

2.

 Creatinine clearance (24‑h urine test)

3.

 Estimated glomerular filtration rate (eGFR) calculated from serum creatinine (based on Cockcroft–
Gault/MDRD equations)

4.

 Imaging (ultrasound of kidneys)

5.

 Any other test, please specify __________________________________

__________________________________________________________________
9. What complications of CKD are you aware of? (Tick all that apply)
1.

 Anemia					2.

 Ischemic heart disease

3.

 Hyperparathyroidism and bone disease

 Metabolic acidosis

5.

 Hyperkalemia				6.

 Volume overload

7.

 Worsening hypertension			

 Malnutrition

9.

 Others _____________________________________________________

4.

8.

10. What level of systolic blood pressure (mm of Hg) control do you target in a patient with CKD?
1.

 >140				2.

 130‑139

3.

 110‑130				4.

 <110

11. What level of diastolic blood pressure (mm of Hg) control do you target in a patient with CKD?
1.

 ≥90				

2.

3.

 60‑80				4.

 80‑89
 <60

12. Which medications do you prescribe as first‑line antihypertensive agent for lowering BP in patients with proteinuria?
(Tick all that apply)

b

1.

 Calcium channel blockers		

2.

 Beta‑blockers

3.

 ACE inhibitor/ARBs		

4.

 Thiazide diuretics
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5.

 Sedative				6.

 Others ___________________

13. What level of HbA1c (%) do you target in diabetic patients with CKD?
1.

 <7.0				2.

 Between 7 and 8

3.

 Between 8 and 9			

 >9.0

4.

14. What level of serum low‑density lipoprotein (LDL mg/dl) do you target in patients with CKD who do not have
any clinical evidence of IHD?
1.

 >160				2.

 130‑159

3.

 100‑129				4.

 <100

5.

 Other _________________

15. At what level of GFR do you refer a patient with CKD to a nephrologist?
1.

 Between 30 and 60 ml/min

2.

 Between 15 and 29 ml/min

3.

 Less than 15 ml/min		

4.

 Do not know

16. Do you read medical journals in order to keep yourself updated?
1.

 Yes				2. No

If yes, name a few of them:
_____________________________________________________________________________________________________
_____________________________________________________________________________________________________
17. Do you participate in Continued Medical Education (CME) activities conducted at tertiary care hospitals?
1.

 Yes				2.

 No

If no, please specify the reason: __________________________________________________________________
* Thanks for your time *
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